Silicone hydrogel lenses

Search documents
COO Stock Declines Despite Strong Core Growth Amid Fertility Woes
ZACKS· 2025-07-02 13:26
Key Takeaways COO grew EPS 14% and expanded operating margin to 24.9% despite macro challenges. Strong gains for COO's MyDay lenses and surgical devices offset weaker fertility and Asia demand. Inventory destocking and tariff risks may pressure COO's revenues and EPS into in fiscal 2026. The Cooper Companies, Inc.’s (COO) strategic investments in innovation and its diversified product base support long-term growth. However, near-term macro and inventory challenges, particularly in fertility and global con ...
CooperCompanies' 2024 Sustainability Report Showcases Efforts that Benefit People and the Planet
GlobeNewswire News Room· 2025-05-20 20:15
Core Insights - CooperCompanies published its 2024 Sustainability Report, highlighting initiatives aimed at fostering positive change for people and the planet, along with updated sustainability performance data [1][2] Group 1: Sustainability Initiatives - In 2024, CooperCompanies focused on reducing its plastic footprint, achieved several sustainability certifications, and made significant investments in employee learning and development programs [2] - The report aligns with the Sustainability Accounting Standards Board (SASB) Standards, a recognized framework for evaluating sustainability performance [3] Group 2: Company Overview - CooperCompanies operates through two main business units: CooperVision, a leader in the contact lens industry, and CooperSurgical, which focuses on fertility and women's healthcare [4] - The company is headquartered in San Ramon, California, employs over 16,000 people, sells products in more than 130 countries, and positively impacts over 50 million lives annually [4]